Diverse Drug-Resistant Cancer Cells Share a Hidden Weakness
UCSF researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types.
University of California San Francisco
Give to UCSFUCSF researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types.
Scientists from Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and the University of California, San Francisco will hold a briefing to discuss Accelerating Therapeutics for Opportunities in Medicine
UCSF researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread.
The NCI has announced that UCSF will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.
The University of California’s five academic cancer centers, have formed a consortium to better address California’s most pressing cancer-related problems and opportunities.
UCSF’s Helen Diller Family Comprehensive Cancer Center is consistently among the world's top five institutions producing the most impactful and utilized research.
A virus hiding quietly in the gut may trigger the onset of a severe complication known as graft-versus-host disease (GvHD) in patients who receive bone marrow transplants.
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study.
Google search volume across the United States could help fill in the gaps on cancer incidence and mortality data, according to a new study by scientists at UCSF and the University of Pennsylvania.
A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UCSF in collaboration with colleagues in Sweden.
Asian-American women are more likely to experience delays in follow-up treatment after an abnormal mammogram compared to white women, according to new UCSF research.
Cancer specialists from UCSF will present new findings at the annual meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting.
Providing healthy women with information about pelvic examinations, including a professional society’s strong recommendation against them, substantially decreases the patients’ desire for the exam.
Colon cancer patients who have a healthy body weight, exercise regularly and eat a diet high in whole grains, fruits and vegetables have a significantly lower risk of cancer recurrence or death.
By piercing liver cells with rapid pulses of electricity, scientists at UC San Francisco have demonstrated an entirely new way to transplant cells into organs to treat disease.
A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy.
Women enrolled in California’s Medicaid program (Medi-Cal) who have been diagnosed with severe mental illness have been screened for cervical cancer at much lower rates than other women.
A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more consistently administered – for common CT scans.
Smoking by either parent helps promote genetic deletions in children that are associated with the development and progression of the most common type of childhood cancer, according to research headed by UCSF.
UCSF researchers have used data-mining computational tools to identify a treatment for hepatocellular carcinoma, a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced.
The chromosomal “balance” of normal and abnormal versions of the cancer-driving gene KRAS affects the response to targeted treatments.
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UCSF, Weill Cornell Medicine and three other medical centers.
Women whose breasts are composed largely of glandular tissue, rather than fat, have an amplified risk of breast cancer, which exceeds the impact of other widely known risks on a population level.
A new study identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.
E-cigarettes – thought by some to be responsible for a decline in youth cigarette smoking – are actually attracting a new population of adolescents who might not otherwise have smoked tobacco products.
New research has found that successful cancer immunotherapy appears to depend on whether the treatment can trigger a system-wide immune response, rather than just a local response within the tumor itself.
UC San Francisco scientists have formed an innovative research alliance with three global pharmaceutical companies.
UCSF researchers have taken a major step toward understanding the function of the tens of thousands of human genes that do not code for proteins, a phenomenon considered one of the key remaining mysteries of the human genome.
To give you a bit of scientific motivation, UCSF gathered some of the latest research behind the most popular health-related New Year’s resolutions that attest to why it really is good for your body to see them through.